Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria

Janet Novotny

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Other: Control

Other: Blackberries

Study type

Interventional

Funder types

Other U.S. Federal agency

NIH

Identifiers

NCT01944579

HS40

Details and patient eligibility

About

Intestinal bacteria can metabolize unabsorbed polyphenols (plant compounds) to produce smaller molecules which may impact health. In addition, evidence suggests that this process may be affected by body fatness. This study aims to investigate absorption of blackberry polyphenols, their impact on intestinal bacteria, polyphenol metabolites formed by intestinal bacteria, and how these processes differ for obese and lean individuals. It is hypothesized that polyphenol absorption and metabolism will differ between obese and lean individuals and that differences in intestinal microbiota may play a role.

Enrollment

46 patients

Sex

All

Ages

25 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

25-75 years old

Exclusion criteria

Use of blood-thinning medications such as Coumadin (warfarin), Dicumarol (dicumarol), or Miradon (anisindione)
Presence of any gastrointestinal disease, metabolic disease, or malabsorption syndromes that may interfere with the study goals
Have been pregnant during the previous 12 months, are currently pregnant or lactating, or plan to become pregnant during the study
Type 2 diabetes requiring the use of oral antidiabetic agents or insulin
Fasting triglycerides greater than 300 mg/dL
Fasting glucose greater than 126 mg/dL
History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)
Use of prescription or over-the-counter antiobesity medications or supplements (e.g., phenylpropanolamine, ephedrine, caffeine) during and for at least 6 months prior to the start of the study or a history of a surgical intervention for obesity
Active cardiovascular disease (such as a heart attack or procedure within the past three months or participation in a cardiac rehabilitation program within the last three months, stroke, or history/treatment for transient ischemic attacks in the past three months, or documented history of pulmonary embolus in the past six months).
Use of any tobacco products in past 3 months
Unwillingness to abstain from herbal supplements for two weeks prior to the study and during the study
Known (self-reported) allergy or adverse reaction to blackberries or other study foods
Unable or unwilling to give informed consent or communicate with study staff
Self-report of alcohol or substance abuse within the past twelve months and/or current acute treatment or rehabilitation program for these problems (Long-term participation in Alcoholics Anonymous is not an exclusion)
Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol